ENSC

2.27

1.34% 0.03

Dopo l'orario di chiusura: 2.22 -0.05 -2.20%

Ensysce Biosciences Inc (ENSC)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$2.24

Aprire:

$2.24

Volume 24 ore:

37,643

Relative Volume:

0.02

Capitalizzazione di mercato:

$4.82M

Reddito:

Utile/perdita netta:

$-11.28M

Rapporto P/E:

-0.7542

EPS:

-3.01

Flusso di cassa netto:

$-9.78M

1 W Prestazione:

+4.13%

1M Prestazione:

+2.25%

6M Prestazione:

-72.48%

1 anno Prestazione:

-68.16%

Intervallo 1D:

$2.205

$2.34

Intervallo di 1 settimana:

$2.15

$2.34

Portata 52W:

$1.62

$14.67

Ensysce Biosciences Inc Stock (ENSC) Company Profile

Nome

Ensysce Biosciences Inc

Settore

Healthcare (1166)

Industria

Biotechnology (655)

Telefono

(858) 263-4196

Indirizzo

7946 IVANHOE AVENUE, LA JOLLA

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

ENSC's Discussions on Twitter

Confronta ENSC con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ENSC Ensysce Biosciences Inc	2.27	4.82M	0	-11.28M	-9.78M	-3.01
VRTX Vertex Pharmaceuticals Inc	457.03	115.95B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	547.74	56.52B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	329.77	39.44B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	545.11	35.14B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	244.32	28.51B	3.81B	-644.79M	-669.77M	-6.24

Ensysce Biosciences Inc Borsa (ENSC) Ultime notizie

Jun 15, 2025

Short Interest in Ensysce Biosciences, Inc. (NASDAQ:ENSC) Declines By 71.5% - Defense World

Jun 15, 2025

Jun 11, 2025

Leading Pain Experts Reveal New Opioid Abuse Prevention Technology at World's Largest Pain Conference - Stock Titan

Jun 11, 2025

(ENSC) On The My Stocks Page - news.stocktradersdaily.com

Jun 11, 2025

Jun 07, 2025

Ensysce Biosciences (NASDAQ:ENSC) Trading 1.7% Higher – Here’s What Happened - Defense World

Jun 07, 2025

Jun 05, 2025

ensysce biosciences appoints baker tilly as new auditor By Investing.com - Investing.com South Africa

Jun 05, 2025

ensysce biosciences appoints baker tilly as new auditor - Investing.com

Jun 05, 2025

Jun 04, 2025

Ensysce Flat on Receiving Grant - Baystreet.ca

Jun 04, 2025

Ensysce Biosciences secures additional $5.3M NIDA grant - Investing.com Australia

Jun 04, 2025

Ensysce Biosciences secures additional $5.3M NIDA grant By Investing.com - Investing.com Canada

Jun 04, 2025

Ensysce Biosciences (ENSC) Secures $5.3M Grant to Advance Opioid Development | ENSC Stock News - GuruFocus

Jun 04, 2025

Revolutionary Opioid With Built-in Overdose Protection Secures $5.3M NIH Grant After FDA Breakthrough Status - Stock Titan

Jun 04, 2025

Jun 01, 2025

Ensysce Biosciences (NASDAQ:ENSC) Raised to Hold at Wall Street Zen - Defense World

Jun 01, 2025

May 29, 2025

Ensysce Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 16, 2025

May 15, 2025

Ensysce Biosciences Advances in Pain Relief Innovation - TipRanks

May 15, 2025

May 13, 2025

Revolutionary Opioid Treatment Proves Overdose-Proof in Clinical Trials, Secures Key Patent - Stock Titan

May 13, 2025

May 12, 2025

Ensysce Biosciences Bolsters Management Team with Regulatory Expert - Stock Titan

May 12, 2025

May 11, 2025

Head-To-Head Contrast: CV Sciences (OTCMKTS:CVSI) and Ensysce Biosciences (NASDAQ:ENSC) - Defense World

May 11, 2025

May 08, 2025

(ENSC) Trading Signals - news.stocktradersdaily.com

May 08, 2025

May 02, 2025

Ensysce Biosciences (ENSC) to Release Earnings on Friday - Defense World

May 02, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 25, 2025

Ensysce Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference - ACCESS Newswire

Apr 25, 2025

Ensysce Biosciences, Inc. Announces Closing of $3.0 Million Registered Direct Offering Priced at-the-Market Under NASDAQ Rules - ACCESS Newswire

Apr 25, 2025